Onconova Therapeutics Inc. (NASDAQ:ONTX) shares traded down 0.8% during trading on Tuesday . The stock traded as low as $3.78 and last traded at $3.88, with a volume of 346,803 shares traded. The stock had previously closed at $3.91.

Separately, Maxim Group set a $6.00 price objective on Onconova Therapeutics and gave the stock a “buy” rating in a research note on Thursday, August 11th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $24.74.

The firm’s market cap is $24.28 million. The stock’s 50 day moving average is $4.03 and its 200 day moving average is $4.72.

Onconova Therapeutics (NASDAQ:ONTX) last issued its earnings results on Monday, August 15th. The biopharmaceutical company reported ($1.96) EPS for the quarter. The firm earned $2.25 million during the quarter. On average, analysts forecast that Onconova Therapeutics Inc. will post ($7.40) earnings per share for the current fiscal year.

Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.